MENU
NVO
Stock ticker: NYSE
PRICE
CHANGE
CAPITALIZATION
Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world... Show more
Industry: #Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
323.27B
P/E Ratio
20.27
Total Cash
N/A
Projected Growth
1.31
Total Debt
N/A
Revenue
N/A
Risk (Beta)
0.57
Dividend Yield
0.02
Total Cash/Share
N/A
Total Debt/Equity
2.39
Revenue/Share
10.38 USD as % of share price
Fundamentals
NVO
Capitalization
323B
P/E Ratio
20.27
Risk (Beta)
0.57
Dividend Yield
0.02
Total Cash
N/A
Total Cash/Share
N/A
Total Debt
N/A
Total Debt/Equity
2.39
Projected Growth (PEG Ratio)
1.31
Revenue/Share (as % of the share price)
10.38%
Revenue
N/A
ROE
N/A
Book Value
N/A
P/B Ratio
15.27
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
N/A
Current Ratio
0.74
Current Revenue Per Employee
1122945.60
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
84.80
Revenue To Assets
N/A
Shares Held By Institutions
90.9B
Shares Outstanding - Current
4.44B
Total Liabilities
N/A
Total Volume MTD
N/A
Value
1
Gain YTD
-18.966
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com